1. Thomas S, Ellertson C et al. Nuisance or natural and healthy: should monthly Menstruation be optional for women? Lancet 2000; 355: 922–4.
2. Andrist L, Raquel D et al. Women's and provides` attitudes towards menstrual suppression with extended use of oral contraceptives. Contraception 2004; 70: 359–63.
3. Milan R Henzl, Polan MI. Avoiding Menstruation. J Reprod Med 2003; 49 (3): 162–74.
4. World Health Organization Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids. Norethindrone enanthate and medroxyprogesterone acetate. Final Report. Contraception 1983; 28: 1–20.
5. World Health Organization Task Force on long-acting systemic agents for fertility regulation: multicenter phase III comparative clinical trial of depot-MPA given three months at doses of 100 mg or 150 mg. Contraceptive efficacy and side effects. Contraception 1986; 34: 223–35.
6. Loudon NB, Fozwell M, Potta DM et al. Acceptability of an oral contraceptive that reduces the frequency of menstruation. The tri-cycle regiment. BMJ 1997; 2: 487–90.
7. Miller L, Notter KM. Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial. Obstet Gynecol 2001; 98: 771–8.
8. Kwiecien M, Edelman A, Nicols AMD et al. Bleeding patterns and patient acceptability of standard or continuous dosing regiments of low-dose oral contraceptive. A randomized trial. Contraception 2003; 67: 9–13.
9. De Voogd WS. Postponement of withdrawal bleeding with a monophasic oral contraceptive containing desogestrel and ethinyl-estradiol. Contraception 1991; 44: 107–12.
10. Strassman BI. The evolution of endometrial cycles and menstruation. Q Rev Biol 1996; 71: 181–220.
11. Sulak PJ, Kuehl TJ, Ortiz M. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol 2002; 186: 1142–49.
12. Sulak P, Cressman B, Waldorp E et al. Extending the duration of active oral contraceptive pills to manage hormone Withdrawal symptoms. Ob Gyn 1997; 89: 181–220.
13. Vircellini P, de Giorgio O et al. Cyproterone acetate versus a continuous oral monophasic contraceptives in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. Fertil Steril 2002; 77: 52061.
14. Baird DT, Glasier AF. Hormonal contraception. N Eng J Med 1993; 328: 1543–49.
15. Гинекология: национальное руководство. Под ред. В.И.Кулакова, И.Б.Манухина, Г.М.Савельевой. М.: ГЭОТАР-Медиа, 2007. / Ginekologiia: natsional'noe rukovodstvo. Pod red. V.I.Kulakova, I.B.Manukhina, G.M.Savel'evoi. M.: GEOTAR-Media, 2007. [in Russian]
16. Манухин И.Б., Тумилович Л.Г., Геворкян М.А. Клинические лекции по гинекологической эндокринологии. М.: ГЭОТАР-Медиа, 2006. / Manukhin I.B., Tumilovich L.G., Gevorkian M.A. Klinicheskie lektsii po ginekologicheskoi endokrinologii. M.: GEOTAR-Media, 2006. [in Russian]
17. Moore J, Kennedy S, Prentice A. Modern combined oral contraceptives for pain associated with endometriosis (Cochrane Review). In the Cochrane Library; Oxford, Issue 1. Oxford: Update Software, 2003.
18. Прилепская В.Н. и др. Руководство по контрацепции. М.: МЕДпресс-информ, 2006. / Prilepskaia V.N. i dr. Rukovodstvo po kontratseptsii. M.: MEDpress-inform, 2006. [in Russian]
19. Ludicke F, Johannison E et al. Effect of oral combined contraceptive containing 3 mg of drospirenone and 30 microgr of ethinyl estradiol on the human endometrium. Fertil Steril 2001; 76: 102–7.
20. Anderson FD, Hait H, Hsiu J et al. Endometrial microstructure after long-term use of an extended-cycle oral contraceptive regimen. Contraception 2005; 71: 55–9.
21. Кулаков В.И., Серов В.Н., Жаров Е.В. Гормональная контрацепция и здоровье женщины. М.: ORGYN, 2006. / Kulakov V.I., Serov V.N., Zharov E.V. Gormonal'naia kontratseptsiia i zdorov'e zhenshchiny. M.: ORGYN, 2006.  [in Russian]
22. Геворкян М.А., Манухин И.Б., Григорова Л.В., Горбунова Е. Профилактика рецидива наружного генитального эндометриоза. Гинекология. 2008; 10 (4): 49–51. / Gevorkian M.A., Manukhin I.B., Grigorova L.V., Gorbunova E. Profilaktika retsidiva naruzhnogo genital'nogo endometrioza. Gynekology. 2008; 10 (4): 49–51. [in Russian]

________________________________________________

1. Thomas S, Ellertson C et al. Nuisance or natural and healthy: should monthly Menstruation be optional for women? Lancet 2000; 355: 922–4.
2. Andrist L, Raquel D et al. Women's and provides` attitudes towards menstrual suppression with extended use of oral contraceptives. Contraception 2004; 70: 359–63.
3. Milan R Henzl, Polan MI. Avoiding Menstruation. J Reprod Med 2003; 49 (3): 162–74.
4. World Health Organization Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids. Norethindrone enanthate and medroxyprogesterone acetate. Final Report. Contraception 1983; 28: 1–20.
5. World Health Organization Task Force on long-acting systemic agents for fertility regulation: multicenter phase III comparative clinical trial of depot-MPA given three months at doses of 100 mg or 150 mg. Contraceptive efficacy and side effects. Contraception 1986; 34: 223–35.
6. Loudon NB, Fozwell M, Potta DM et al. Acceptability of an oral contraceptive that reduces the frequency of menstruation. The tri-cycle regiment. BMJ 1997; 2: 487–90.
7. Miller L, Notter KM. Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial. Obstet Gynecol 2001; 98: 771–8.
8. Kwiecien M, Edelman A, Nicols AMD et al. Bleeding patterns and patient acceptability of standard or continuous dosing regiments of low-dose oral contraceptive. A randomized trial. Contraception 2003; 67: 9–13.
9. De Voogd WS. Postponement of withdrawal bleeding with a monophasic oral contraceptive containing desogestrel and ethinyl-estradiol. Contraception 1991; 44: 107–12.
10. Strassman BI. The evolution of endometrial cycles and menstruation. Q Rev Biol 1996; 71: 181–220.
11. Sulak PJ, Kuehl TJ, Ortiz M. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol 2002; 186: 1142–49.
12. Sulak P, Cressman B, Waldorp E et al. Extending the duration of active oral contraceptive pills to manage hormone Withdrawal symptoms. Ob Gyn 1997; 89: 181–220.
13. Vircellini P, de Giorgio O et al. Cyproterone acetate versus a continuous oral monophasic contraceptives in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. Fertil Steril 2002; 77: 52061.
14. Baird DT, Glasier AF. Hormonal contraception. N Eng J Med 1993; 328: 1543–49.
15. Ginekologiia: natsional'noe rukovodstvo. Pod red. V.I.Kulakova, I.B.Manukhina, G.M.Savel'evoi. M.: GEOTAR-Media, 2007. [in Russian]
16. Manukhin I.B., Tumilovich L.G., Gevorkian M.A. Klinicheskie lektsii po ginekologicheskoi endokrinologii. M.: GEOTAR-Media, 2006. [in Russian]
17. Moore J, Kennedy S, Prentice A. Modern combined oral contraceptives for pain associated with endometriosis (Cochrane Review). In the Cochrane Library; Oxford, Issue 1. Oxford: Update Software, 2003.
18. Prilepskaia V.N. i dr. Rukovodstvo po kontratseptsii. M.: MEDpress-inform, 2006. [in Russian]
19. Ludicke F, Johannison E et al. Effect of oral combined contraceptive containing 3 mg of drospirenone and 30 microgr of ethinyl estradiol on the human endometrium. Fertil Steril 2001; 76: 102–7.
20. Anderson FD, Hait H, Hsiu J et al. Endometrial microstructure after long-term use of an extended-cycle oral contraceptive regimen. Contraception 2005; 71: 55–9.
21. Kulakov V.I., Serov V.N., Zharov E.V. Gormonal'naia kontratseptsiia i zdorov'e zhenshchiny. M.: ORGYN, 2006.  [in Russian]
22. Gevorkian M.A., Manukhin I.B., Grigorova L.V., Gorbunova E. Profilaktika retsidiva naruzhnogo genital'nogo endometrioza. Gynekology. 2008; 10 (4): 49–51. [in Russian]

В.В.Коренная*1, К.Н.Кайибханова1, Е.А.Любимова2, В.В.Агишева2

1. ГБОУ ДПО Российская медицинская академия последипломного образования Минздрава России. 123995, Россия, Москва, ул. Баррикадная, д. 2/1;
2. Швейцарская университетская клиника. 109240, Россия, Москва, ул. Николоямская, д. 19, стр. 1
*drkorennaya@mail.ru

________________________________________________

V.V.Korennaya*1, K.N.Kayibkhanova1, E.A.Liubimova2, V.V.Agisheva2

1. Russian Medical Academy for Postgraduate Education of the Ministry of Health of the Russian Federation. 123995, Russian Federation, Moscow, ul. Barrikadnaia, d. 2/1;
2. Swiss University Clinic. 109240, Russian Federation, Moscow, ul. Nikoloiamskaia, d. 19, str. 1
*drkorennaya@mail.ru